In recent years, the "Personalized Medicine Project（*）" and similar research projects have begun to reveal the relationships between genes and disease, as well as the relationships between genes and the efficacy and side effects of drugs. RIKEN GENESIS has launched a range of initiatives to apply the results of this research in clinical settings.
RIKEN GENESIS is collaborating with RIKEN and Toppan Printing on the joint development of a fast desktop system for SNP genotyping, which is being utilized in clinical research.

（*）The "Personalized Medicine Project" involves the collection of DNA and serum samples from 300,000 people in a biobank and their use to reveal the relationships between SNPs (differences in individual genes) and drug efficacy and side effects, as well as to investigate the relationship between genetic differences and disease, with the aim of laying the foundations for personalized medicine.

For details, see the BioBank Japan website.